Zobrazeno 1 - 10
of 106
pro vyhledávání: '"osteosarcoma cell lines"'
Autor:
Jana Dvorakova, Lucie Wiesnerova, Petra Chocholata, Vlastimil Kulda, Lukas Landsmann, Miroslava Cedikova, Michaela Kripnerova, Lada Eberlova, Vaclav Babuska
Publikováno v:
BioMedical Engineering OnLine, Vol 22, Iss 1, Pp 1-28 (2023)
Abstract Bone regeneration after injury or after surgical bone removal due to disease is a serious medical challenge. A variety of materials are being tested to replace a missing bone or tooth. Regeneration requires cells capable of proliferation and
Externí odkaz:
https://doaj.org/article/de87eade416b47b396abf22bf98b2fe3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yi-Hsien Hsieh, Wen-Hung Hsu, Shun-Fa Yang, Chung-Jung Liu, Ko-Hsiu Lu, Pei-Han Wang, Renn-Chia Lin
Publikováno v:
Pharmaceuticals, Vol 14, Iss 3, p 260 (2021)
Timosaponin AIII (TSAIII) is a steroidal saponin which demonstrates anti-tumour activities. However, the effect of TSAIII on human osteosarcoma cells remains largely unknown. In this study, we demonstrated that TSAIII exerted a significant inhibitory
Externí odkaz:
https://doaj.org/article/83a096e2e4d74b04846ef5de1cc71a5a
Autor:
Pracheta Sengupta, Sukanya Raman, Rajdeep Chowdhury, K. Lohitesh, Heena Saini, Sudeshna Mukherjee, Atish Paul
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
Cancer is a multifactorial disease and hence can be effectively overcome by a multi-constituently therapeutic strategy. Medicinal plant extracts represent a perfect example of such stratagem. However, minimal studies have been done till date that por
Externí odkaz:
https://doaj.org/article/931cffcf9dea4dcb9dfa7c41a8a03e8a
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
This study highlights the relevance of network-guided controllability analysis as a precision oncology tool. Target controllability through networks is potentially relevant to cancer research for the identification of therapeutic targets. With refere
Externí odkaz:
https://doaj.org/article/2c73ddd402d6489cac55afc79aca49f2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 45, Iss 4, Pp 307-312 (2006)
Objective: To evaluate the expression of estrogen receptors (ER) a and b, and activity of alkaline phosphatase during differentiation of primary osteoblast cells (hOB) from aged postmenopausal women and human osteosarcoma cell lines (HOS, MG63). Mate
Externí odkaz:
https://doaj.org/article/343dadf5e8b34a50bb4f290f5805378a
Publikováno v:
Evolutionary Bioinformatics
Evolutionary Bioinformatics, Vol 17 (2021)
Evolutionary Bioinformatics, Vol 17 (2021)
The etiology of osteosarcoma (OS) is complex and not fully understood till now. This study aimed to identify the miRNAs, circRNAs, and genes (mRNAs) that are differentially expressed in OS cell lines to investigate the mechanism of circRNA-associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5255af55e6471822dea9355a415d37b8
https://pubmed.ncbi.nlm.nih.gov/34707339
https://pubmed.ncbi.nlm.nih.gov/34707339
Autor:
Ko-Hsiu Lu, Shun-Fa Yang, Chung-Jung Liu, Yi-Hsien Hsieh, Renn-Chia Lin, Wen-Hung Hsu, Pei-Han Wang
Publikováno v:
Pharmaceuticals
Volume 14
Issue 3
Pharmaceuticals, Vol 14, Iss 260, p 260 (2021)
Volume 14
Issue 3
Pharmaceuticals, Vol 14, Iss 260, p 260 (2021)
Timosaponin AIII (TSAIII) is a steroidal saponin which demonstrates anti-tumour activities. However, the effect of TSAIII on human osteosarcoma cells remains largely unknown. In this study, we demonstrated that TSAIII exerted a significant inhibitory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::188298689e528eaa3522dfa3f8601924
http://europepmc.org/articles/PMC8000016
http://europepmc.org/articles/PMC8000016
Publikováno v:
Animals; Volume 12; Issue 7; Pages: 866
The study discusses in vitro cytotoxicity of a combination of cytostatic drugs (doxorubicin, cisplatin, carboplatin, etoposide) and risedronate sodium against canine and human osteosarcoma (D-17 and U-2 OS). Standard protocols were used for the prepa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddefbe61cab6b7f2a3ab6d2e8384081e
https://doi.org/10.3390/ani12070866
https://doi.org/10.3390/ani12070866